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Abstract  
 
Background: This study aimed to determine whether the TREZZO HS Advanced foam mattress  
system could reduce the use of dynamic mattress systems (Alternating and Constant Low Pressure) 
in patients on vascular and stroke wards. Methods: TREZZO HS mattresses were evaluated in a 
vascular and stroke wards over a 6-week period with respect to the outcome of reduction in need 
for dynamic mattress use and any affect on skin integrity. Data was compared with corresponding 
retrospective data from the previous year in which high specification pressure reducing foam 
mattresses were available. Mean length of patient stay on both types of mattresses, and the 
dynamic mattress, was evaluated. Cox semiparametric time-to-event methods were used to assess 
the hazard of patient transfer to a dynamic mattress in patients positioned on TREZZO HS, rather 
than the previously used foam mattress. Results: Use of the TREZZO system reduced mean length of 
stay on a dynamic mattress by 70% over both wards; from 41.0 days to 12.6 days. The proportion of 
patient-days spent on dynamic mattress systems decreased from 47.8% to 7.1%. Mattress type was 
significantly associated with the event (p=0.036); hazard ratio 0.328 (95% confidence interval 0.116 
to 0.929). Ward type was not significantly associated with the event (p=0.333). Conclusion:  The 
TREZZO HS system has been shown to substantially reduce the use of dynamic mattress usage and 
may be a cost-effective way of reducing the likelihood of pressure ulceration in vascular and stroke 
patients. 
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Introduction  
Increased pressure is placed on tissue viability nurses, and other healthcare professionals, to minimise 
the number of pressure ulcers occurring in clinical practice. This must be achieved whilst ensuring 
expenditure on recommended pressure-redistributing  equipment is confined within the constraints 
of the limited budgets available (Gleeson, 2015; Oliveira, Nascimento, Nicolussi, Chavaglia, Araújo, & 
Barbosa, 2017). The Health and Social Care Information Centre (2013) report that the average 
inpatient length of stay is 5.6 days, which greatly increases by a further 5-8 days upon development 
of a hospital-acquired pressure ulcer (Dealey, Posnett & Walker, 2012).  
 
One reason to explain the delay in discharge could be lack of availability of necessary pressure-
relieving equipment within the community (Hampton, 2000). Development of pressure ulcers can 
have serious repercussions for both patient and hospital resources. For patients, additional 
unnecessary distress could be caused due to the over-extended stays, pain and discomfort 
experienced, alongside the potential for bed-blocking; preventing the admission of others in need of 
hospital treatment (McInnes, Jammali-Blasi, Bell-Syer, Dumville, Middleton & Cullum, 2015). The daily 
management of pressure ulcers is estimated to incur a cost of between £43 to £374, dependent on 
the associated complications, in addition to the costs of standard care (Dealey, Posnett & Walker, 
2012; NICE, 2014). Indeed Clancy (2013) estimated the 2012 NHS spend on rental and purchase of 
pressure redistributing mattresses and beds to be in excess of £100m.  
 
Oliveira et al (2017) emphasises the great number of pressure-redistributing  systems available for use 
in practice and affirms that healthcare providers’ choice should involve a multitude of factors, 
including: recommendations through evidence-based research, financial issues and availability. A 
systematic review conducted by McInnes et al (2015) identified that patients placed on standard 
hospital foam mattresses had an increased likelihood of developing a pressure ulcer in comparison to 
those on an high specification foam or dynamic mattress (constant low pressure and alternating 
pressure). Dynamic mattresses, however, remain to be judged as the pinnacle of pressure ulcer 
prevention (Gleeson, 2015; McInnes et al, 2015). There is a considerable difference in cost between 
the two systems: high-specification foam mattresses cost around £120-£200; and dynamic mattresses 
cost around £3,500-£3,600 (NICE, 2014).  
 Given the current climate surrounding effective use of healthcare resources and funding, it is essential 
to investigate ways in which cost can be reduced whilst maintaining high quality care for patients. 
Savings can be made by continuing to prevent pressure ulcers. The NHS Safety Thermometer reported 
that in June 2016, 4.4% of reported patients had developed pressure ulcers in hospital. Ensuring 
appropriate use of dynamic systems in practice could also substantially save NHS funding. The aim of 
this study was to evaluate whether the TREZZO HS Advanced static system, shown in figure 1, could 
reduce the use of dynamic mattress systems. Secondary outcome measures included monitoring of 
the incidence in pressure damage in patients positioned on different systems.  
 
 
Figure 1: The TREZZO HS Advanced Foam Mattress System, consisting of a 40 Kg foam density split 
into three zones. The open cell structure allows airflow, which combined with the infused micro gel 
beads help to regulate temperature (Ousey, Stephenson & Fleming, 2016). 
 
 
Methods 
The TREZZO HS advanced foam mattress system, as supplied by Essential Healthcare, was clinically 
evaluated at two sites (one stroke and one vascular unit) in the North West of England. Prior to 
conducting the evaluations, ethical approval was sought and granted by The University of Huddersfield 
School of Human and Health Sciences Research Ethics Panel, in addition to Research Governance 
permission from both Trusts.  
 
Essential Healthcare provided training to the staff at each site prior to installation of the TREZZO HS 
advanced system; highlighting correct use of the system. A total of 57 systems were distributed to the 
wards, where all high specification pressure reducing foam mattresses systems were replaced with 
the TREZZO HS. Site 1 received 26 mattresses and Site 2 received 31 mattresses. All patients nursed in 
the clinical areas were included in the evaluation; however, any patient who required a powered 
pressure-redistributing system, as assessed by the nursing staff, was transferred according to hospital 
policy.  
 
The evaluation consisted of a comparison between retrospective and prospective data collected at 
patient level over a period of 6 weeks. Prospective data was collected using questionnaires completed 
by the clinical ward staff. The retrospective data was gathered from the patient notes during the same 
period in the previous 12 months: for instance, retrospective data was collected in April 2016 for 6 
weeks and prospective collected in April 2017 for 6 weeks.  
 
Patient data from both wards was recorded, including: date of admission, demographics (age, gender, 
co-morbidities), the type of mattress, details of any mattress transfer, results of skin damage 
assessment, Waterlow scores and date of discharge (if before the 6 weeks). Following inspection of 
admission and discharge timings of patients with identical admission and discharge dates, any patient 
who spent less than 2 hours on the ward was removed from the data set.  
 
Dates (and times where available) of admission, discharge and transfer were used to calculate the 
times spent by each patient on each type of mattress from which the total number of patient-days 
spent on each type of unit, mean length of hospital stay amongst patients positioned on that unit, and 
the proportion of patient-days spent by patients on dynamic mattress systems were determined. Any 
incidences of pressure ulceration of any category were also recorded; however, due to expected low 
incidences, no distinction was made between different categories. 
 
Retrospective data was provided by the Tissue Viability Lead or Ward Manager at the site to the 
research team at the University of Huddersfield. All the data provided was anonymised and no 
identifying patient data was collected.  
 
The primary analysis was based on time-to-event methods, with the event of interest being transfer 
to a dynamic mattress from a non-dynamic mattress. Cox semi-parametric methods were utilised for 
this procedure, with the key grouping predictor variable considered to be mattress type (high 
specification pressure reducing foam mattresses in the case of retrospective (2016) data; and the 
TREZZO mattress in the case of prospective (2017) data). Noting that different institutions may have 
different policies regarding placing patients on dynamic mattress systems, ward type was also 
considered to be a key grouping variable. Patient age, gender and Waterlow score were considered 
to be controlling variables. 
 
A sequential Cox model was derived, with controlling variables entered as a block in the initial step; 
and the key variables of type of mattress and type of ward forced entered at a second step alongside 
any controlling variables qualifying from the first step by exhibiting an association of substantive 
importance with the event of interest (transfer of patient from mattress to dynamic mattress). The 
proportionality of hazards assumption in the Cox model was tested by the testing of interactions 
between all included variables and the logarithm of the time variable. Non-significance interactions 
(i.e. those revealing no evidence for non-proportionality of hazards) were removed once 
proportionality had been established before construction of the final model. This analysis included 
only those patients who were initially placed on a non-dynamic mattress; and hence were “at risk” of 
the event under investigation.  
 
The significance of individual parameters in the model was assessed, with hazard ratios and associated 
95% confidence intervals, also reported. The proportionality of hazards assumption in the Cox model 
was tested by the testing of interactions between all included variables and the logarithm of the time 
variable. These interactions were removed from the final model once proportionality had been 
established.  
 
 
 
Results 
 
Valid retrospective data was obtained from 175 patients on the vascular ward and 52 patients on the 
stroke ward; i.e. 227 patients in total. Valid prospective data was obtained from 27 patients on the 
vascular ward and 45 patients on the stroke ward; i.e. 72 patients in total. Thus a grand total of 298 
patients were included in the analysis.  
Patient demographics are summarised descriptively in Table 1 below  
Table 1: summary of patient demographics 
 Retrospective data Prospective data Grand total 
 Vascular Stroke Total Vascular Stroke Total  
Gender (frequency (%) 
   Male 
   Female 
 
109 (62.3%) 
66 (37.7%) 
 
15 (28.8%) 
37 (71.2%) 
 
124 (54.6%) 
103 (45.4%) 
 
20 (76.9%) 
6 (23.1%) 
 
21 (46.7%) 
24 (53.3%) 
 
41 (57.7%) 
30 (42.3%) 
 
165 (55.4%) 
133 (44.6%) 
Age (years) (mean (SD)) 58.3 (19.6) 76.4 (14.7) 62.4 (12.6) 63.6 (14.1) 75.7 (12.5) 71.2 (14.3) 64.5 (19.2) 
Waterlow score (mean (SD)) 11.1 (7.62) 17.0 (5.67) 12.6 (7.61) 16.2 (7.09) 14.0 (5.12) 14.9 (5.98) 13.3 (7.24) 
        
 
 
Hence some difference in age and gender between retrospective and prospective cohorts are 
apparent. However, the magnitude of these differences does not appear to be sufficient to expect a 
substantive effect on outcome measures. Due to differences in the definitions of risk bands using the  
Waterlow score, mean risk statuses are different in different wards. For retrospective data, the mean 
risk score in vascular patients (11.1) corresponds to the status of “At risk”;  whereas the mean risk 
score in stroke patients (17.0) corresponds to the status of “High risk”.  For prospective data, the mean 
risk score in vascular patients (16.2) corresponds to the status of “High risk”;  whereas the mean risk 
score in stroke patients (14.0)  corresponds to the status of “At risk”.   
Mattress allocation– retrospective data 
On the vascular ward, of those patients whose status could be determined, 175 were initially 
positioned on a high specification pressure reducing foam mattress. Seven of these patients (4.0%) 
were subsequently transferred to a dynamic mattress before discharge, transfer or death; with the 
remaining 168 patients remaining on a high specification pressure reducing foam mattress until 
discharge, transfer or death. Four patients were initially positioned on a dynamic mattress; all of 
whom remained on the dynamic mattress until discharge, transfer or death. 
 
On the stroke ward, of those patients whose status could be determined, 27 were initially positioned 
on a high specification pressure reducing foam mattress; Six of these patients (22.2%) were 
subsequently transferred to a dynamic mattress before discharge, transfer or death; with the 
remaining 21 patients remaining on a high specification pressure reducing foam mattress until 
discharge, transfer or death. 23 patients were initially positioned on a dynamic mattress; all of whom 
remained on the dynamic mattress until discharge, transfer or death. Data was unavailable for 2 
patients. 
 
Hence over both wards, 202 patients were initially positioned on a high specification pressure 
reducing foam mattress, with 13 (6.4%) being subsequently transferred to a dynamic mattress. 27 
patients were initially positioned on a dynamic mattress with no subsequent transfers. Patient 
positioning movements over both wards are summarised in Figure 2. 
Figure 2: patient positioning (retrospective data) 
 In both vascular and stroke wards, mean lengths of stay for patients positioned on dynamic mattress 
systems were substantially greater than for patients positioned on high specification pressure 
reducing foam mattresses. Hence, although the majority of patients were positioned on high 
specification pressure reducing foam mattresses, the total patient-days spent on each mattress type 
was similar (Table 2).  
 
Table 2: summary of patient-days spent on high specification pressure reducing foam mattresses and 
dynamic mattress systems (retrospective data) 
 
Ward Mattress Total patient days Mean length of stay 
(days) 
Proportion of 
patient-days on 
dynamic mattress 
systems 
Vascular High specification 
pressure reducing 
foam mattress 
1238.7 7.1 22.5% 
Dynamic mattress 358.6 32.6 
Stroke High specification 
pressure reducing 
foam mattress 
282.0 10.4 78.6% 
Dynamic mattress 1034.0 45.0 
Total High specification 
pressure reducing 
foam mattress 
1520.7 7.5 47.8% 
Dynamic mattress 1392.6 41.0 
 
 
Mattress allocation– prospective data 
On the vascular ward, 26 patients initially positioned on a TREZZO mattress. Five of these patients 
(19.2%) were subsequently transferred to a dynamic mattress before discharge, transfer or death; 
with the remaining 21 patients remaining on a TREZZO mattress until discharge, transfer or death. 
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One patient was initially positioned on a dynamic mattress; and subsequently transferred to a TREZZO 
mattress before discharge, transfer or death. 
 
On the stroke ward, 29 patients (64.4%) were initially positioned on a TREZZO mattress. In addition, 
15 patients were positioned on a high specification pressure reducing foam mattresses at the start of 
the study period but subsequently transferred to a TREZZO mattress during the course of the study. 
These patients were also considered to be available for analysis, with their date of entry to the study 
considered to be the date of their transfer to the TREZZO mattress. Of these 44 patients, three patients 
(6.8%) were subsequently transferred to a dynamic mattress before discharge, transfer or death; with 
the remaining 41 patients remaining on a TREZZO mattress until discharge, transfer or death. One 
patient was initially positioned on a dynamic mattress and was subsequently transferred to a TREZZO 
mattress. 
 
Hence over both wards, 70 patients were initially positioned on a high specification pressure reducing 
foam mattress, with 8 (11.4%) being subsequently transferred to a dynamic mattress (with one patient 
subsequently returned to a TREZZO mattress). 2 patients were initially positioned on a dynamic 
mattress; both of whom were subsequently transferred to a TREZZO mattress. Patient positioning 
movements over both wards are summarised in Figure 3. Column headings refer to the status of all 
patients after transfer processes were completed. 
 
Figure 3: patient positioning (prospective data) 
  
In both vascular and stroke wards, lengths of stay for patients positioned on TREZZO mattresses were 
greater than for patients positioned on dynamic mattress systems; with over 90% of patient-days 
being spent on TREZZO mattresses. (Table 2). 
 
Table 2: summary of patient-days spent on TREZZO mattresses and dynamic mattress systems (prospective 
data) 
 
Ward Mattress Total patient days Mean length of stay (days) Proportion of patient-
days on dynamic 
mattress systems 
Vascular TREZZO mattress 423 15.7 9.4% 
Dynamic mattress 44 7.3 
Stroke TREZZO mattress 1218 27.1 6.3% 
Dynamic mattress 82 20.5 
Total TREZZO mattress 1641 22.8 7.1% 
Dynamic mattress 126 12.6 
 
Hence the use of the TREZZO mattresses resulted in a reduction of the mean length of stay on a 
dynamic mattress from 41.0 days to 12.6 days; representing a decrease in usage of 28.4 days; about 
70%. This benefit occurred in approximately equal measure in both types of wards. The proportion of 
patient-days spent on dynamic mattress systems decreased from 47.8% to 7.1%; approximately a 7-
fold decrease.  
 
 
Cox analysis 
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The first step of the sequential Cox model, including all controlling variables, revealed that Waterlow 
score exhibited an association of substantive importance with the event of interest (transfer of patient 
from foam mattress to dynamic mattress). This is to be expected as most policies use the Waterlow 
score as an indicator for stepping up to a powered mattress. This variable was carried forward for 
inclusion in the second step of the model with the key variables type of mattress and type of ward. 
Inclusion of the interaction terms between included factors and the ln (time) variable revealed no 
evidence for non-proportionality of hazards, with all such interactions being non-significant.  
 
After removal of the interaction terms, the final multiple Cox regression revealed that controlling for 
type of ward and Waterlow score, type of mattress was significantly associated with the time to 
transfer to a dynamic mattress (p=0.036). The hazard ratio for type of mattress of 0.328 (95% 
confidence interval 0.116 to 0.929) indicated that at best estimate, the hazard of transfer to a dynamic 
mattress for patients positioned on a TREZZO mattress was approximately one third of the hazard of 
transfer to dynamic mattress systems amongst patients placed on standard foam mattresses. 
Controlling for type of mattress and type of ward, Waterlow score was also revealed to be significantly 
associated with the time to transfer to a dynamic mattress (p=0.019). The hazard ratio for Waterlow 
score of 1.078 (95% confidence interval 1.013 to 1.148) indicated that at best estimate, the hazard of 
transfer to a dynamic mattress was raised by about 8% for each additional point on the Waterlow 
scale. Ward type, was not significantly associated with the hazard of patient transfer (p=0.333).  
 
Figure 4 below indicates survival to transfer for patients on the two mattress types. 
Figure 4: survival to transfer to dynamic mattress systems for patients on high specification pressure reducing 
foam mattresses and Trezzo mattresses 
 
 
Pressure ulceration 
The incidence of pressure ulceration in both wards, in both analysis periods, was low. In the vascular 
unit, during the retrospective data collection period, two Grade 2 and one unclassified pressure ulcers 
were recorded. One of the Grade 2 ulcers was recorded on a patient who was admitted on a high 
specification pressure reducing foam mattress but was subsequently transferred to a dynamic 
mattress. Prospectively, two of the participants recruited had existing Grade 2 pressure ulcers and 
were still placed onto the TREZZO HS mattress.   
In the stroke ward, a single Grade 3 pressure ulcer was recorded on a patient positioned on a dynamic 
mattress during the prospective data collection period. In all cases, the system (i.e. foam mattress or 
dynamic mattress) being used by the patient when the pressure ulcer was first observed was not 
recorded. The overall frequency of ulceration was too low for statistical analysis. 
 
Discussion  
 
All patients included in the evaluation were considered high risk due to: the nature and typical 
presenting complaints on the wards; patients’ ages; Waterlow scores; and co-morbidities (Gleeson, 
2015). The findings of the evaluations on these high-risk patients clearly demonstrates the benefit of 
implementing the TREZZO HS advanced system in clinical practice on stroke and vascular wards. 
Replacing the high specification pressure reducing foam mattresses with TREZZO HS resulted in a 
reduction in the average length of stay of patients who had transferred on to a dynamic mattress from 
41.0 to 12.6 days (i.e. a reduction of about 70%). While as a non-experimental study it is not possible 
to ascribe all changes in a particular outcome measure to a specific exposure factor, it is possible to 
be confident that any effect of gender, age or Waterlow score was not acting in the same direction as 
the “mattress effect”. Ages and gender proportions of patients on the vascular wards were very similar 
in the 2 cohorts; Waterlow scores actually increased. This increase would be expect to act in the 
opposite direction, if any, to that observed. No  evidence for any systematic changes in the patient 
characteristics between the two cohorts with respect to any other characteristic was observed. 
This was achieved despite higher mean Waterlow scores recorded in the prospective patient cohort 
(14.9) compared with the retrospective patient cohort, before the introduction of the TREZZO system 
(12.6); i.e. the TREZZO system was being used by patients who were at higher risk than those using 
foam mattresses. The selection criteria for the mattresses during the trial in both Trusts was in 
accordance with their existing respective policies: TREZZO equipment was provided for 
patients at very high risk (taking into consideration risk assessment score and clinical 
judgement) with up to Category 2 Pressure Ulcers who were physically and cognitively able 
to reposition themselves. This suggests that there was little confidence amongst staff in 
utilising their previous foam mattress for this profile of patient.  
Hence the potential exists to instil greater confidence within clinicians, supporting them in 
achieving greater cash releasing savings within ever-challenging budgets. The costing report by 
NICE (2014) emphasises that the daily rental costs of a dynamic mattress are approximately £14 per 
day. Hence the 70% reduction in length of stay on dynamic mattress systems associated with the use 
of the TREZZO HS systems highlights a potential for considerable cost savings. The reduction in the 
overall proportion of patient-days spent on dynamic mattress systems following the introduction of 
the TREZZO equipment (from 47.8% to 7.1%) implies lower requirement for the dynamic mattress 
systems and thus lower associated expenditure.  
 The patients who were transferred from the TREZZO HS to a dynamic mattress had a significant 
decrease in their mobility during their stay as a result of the scheduled surgery rather than a 
deterioration in skin integrity due to the mattress. Although no comparisons of pressure ulcer 
incidence could be made between mattress types, as pressure ulcer incidence was minimal, patients 
who were positioned on a standard foam mattress were three times more likely to transfer to a 
dynamic mattress compared to those who were placed on a TREZZO HS system. It is evident that the 
TREZZO HS outperformed the high specification pressure reducing foam mattresses in terms of its 
ability to reduce the use of dynamic mattress systems in high risk patients.  
 
It could be argued that the multi-factorial variables involved in managing the high risk patients being 
investigated could have impacted on the primary outcome of the evaluation. However, the large 
differences found between the retrospective and prospective data of dynamic mattress usage 
validates the conclusion that the TREZZO HS has had a major role to play in the reduction. Further 
research is required to investigate the cost-effectiveness of the use of the TREZZO HS system in order 
to attain details of these savings. 
 
Conclusion  
The findings demonstrate that the TREZZO HS advanced system is effective at reducing the use of 
dynamic mattress systems on stroke and vascular wards. This improved use of dynamic mattress 
systems could enable lucrative savings for health care providers.  
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